DSS, Inc. (DSS)
| Market Cap | 55.75M |
| Revenue (ttm) | 28.11M |
| Net Income (ttm) | -35.07M |
| Shares Out | 139.02M |
| EPS (ttm) | -0.52 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 113,927 |
| Open | 0.400 |
| Previous Close | 0.409 |
| Day's Range | 0.396 - 0.409 |
| 52-Week Range | 0.330 - 1.580 |
| Beta | 1.55 |
| Analysts | Buy |
| Price Target | 2.04 (+408.7%) |
| Earnings Date | Aug 22, 2022 |
About DSS
DSS, Inc. operates in the product packaging, biotechnology, direct, commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy businesses worldwide. It manufactures, markets, and sells custom folding cartons, mailers, photo sleeves, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. The company also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on... [Read more...]
Financial Performance
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for DSS stock is "Buy." The 12-month stock price forecast is 2.04, which is an increase of 408.73% from the latest price.
News
DSS Announces Licensing of Impact BioMedical's Linebacker Portfolio to ProPhase Labs
ROCHESTER, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to...
DSS Strengthens and Expands Board with Appointment of Two Independent Directors
ROCHESTER, N.Y., July 13, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to...
Impact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound Eq...
HENRIETTA, N.Y., June 28, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE American: DSS), along with its scientific research partner Global Research and Di...
DSS's Impact BioMedical Receives China Patent for its Functional Fragrance Formulation Mosquito Repellant
China is one of the leading markets globally for insect repellants China is one of the leading markets globally for insect repellants
DSS, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®
ROCHESTER, N.Y., May 06, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to ...
CORRECTION - DSS Announces Letter to Shareholders
ROCHESTER, N.Y., Feb. 28, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by DSS, Inc. (NYSE American: DSS), please note that in paragraph fourteen, [With more than $1...
DSS to Present at Aegis Virtual Conference
ROCHESTER, N.Y., Feb. 22, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth industries,...
DSS Receives $17 Million Investment from Alset EHome International
ROCHESTER, N.Y., Jan. 25, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth industries,...
DSS Shareholder Alset EHome To Raise Stake To 55.52%
DSS Inc (NYSE: DSS) has entered a stock purchase agreement with its shareholder Alset EHome International Inc. (AEI), which owns 15.24% of its outstanding shares. Under the agreement, AEI sold 877.24 mi...
DSS Acquires 25.1% of Alset International Limited
DSS adds True Partner Capital with $1.7B AUM into DSS Securities; greatly enhancing the portfolio of the finance and asset management division of DSS
DSS Expands American Medical REIT Subsidiary with Acquisition of 21,900 Sq. Ft. Medical Office Building
Six years remaining on lease for primary tenant at Winter Haven, Florida property Six years remaining on lease for primary tenant at Winter Haven, Florida property
Impact BioMedical Announces New Bioplastics Test Results
ROCHESTER, N.Y., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE American: DSS) along with its scientific research partner Global Research and Dis...
DSS Provides Update on Expansion of Premier Packaging Subsidiary
New 105,000 sq. ft. facility more than doubles Premier's capacity to produce sustainable fiber-based packaging solutions for a wide variety of consumer products New 105,000 sq. ft. facility more than do...
DSS's American Pacific Bancorp Approaches $20M in New Loans Issued
ROCHESTER, N.Y., Dec. 20, 2021 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth industries,...
DSS Opens Sacramento Office for its DSS Wealth Management and DSS AmericaFirst Quantitative Funds
ROCHESTER, N.Y., Dec. 15, 2021 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating business segments in blockchain security, direct marketing, ...
DSS to Present at the Emerging Growth Conference on December 8
ROCHESTER, N.Y., Dec. 07, 2021 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating business segments in blockchain security, direct marketing, ...
DSS Enters Quantitative Investment Fund Arena
ROCHESTER, N.Y., Nov. 30, 2021 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating business segments in blockchain security, direct marketing, ...
DSS Expands American Medical REIT with Acquisition of Three Established Acute Care Hospitals in Texas and Pennsylvania
ROCHESTER, N.Y., Nov. 04, 2021 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating business segments in blockchain security, direct marketing, ...
Document Security Systems, Inc. to Change Its Name to DSS, Inc. to Reflect Sweeping Organizational Changes and Ongoin...
ROCHESTER, N.Y., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating business segments in blockchain secur...
Alset EHome International Inc.'s American Pacific Bancorp Subsidiary Receives USD $40 Million Investment from Documen...
BETHESDA, MD / ACCESSWIRE / September 9, 2021 / Alset EHome International Inc. (NASDAQ:AEI) ("AEI" the "Group" or "Company"), a diversified holding company principally engaged through its subsidiaries i...
DSS Subsidiary Impact Biomedical Reports Positive Test Results For 3FDB DEET Booster Technology
Document Security Systems, Inc. (NYSE: DSS), subsidiary Impact Biomedical, Inc, along with its scientific research partner Global Research and Discovery Group Sciences, GRDG, announced encouraging resul...
DSS's Impact BioMedical Reports Positive Test Results for its 3FDB “DEET Booster” Technology
Mosquito repellent booster technology with wide application potential Mosquito repellent booster technology with wide application potential
Document Security Systems Names Todd Macko Finance Chief
Document Security Systems, Inc. (NYSE: DSS) announced the promotion of Todd D. Macko to Chief Financial Officer effective August 16, 2021.
Document Security Systems Invests $1M In Vivacitas Oncology
Document Security Systems Inc's (NYSE: DSS) subsidiary, DSS Biomedical International, Inc., has completed a $1 million equity investment in Vivacitas Oncology, Inc. Vivacitas Oncology focuses on develop...